loading

Cns Pharmaceuticals Inc Stock (CNSP) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
34.10%
3.5449
5.3794 4.5338 4.0254 4.9265
Interest Income/Expense
129.95%
0.00663
0.00288 0.00184 0.00365 0.00544
Operating Income/Loss
34.10%
-3.5449
-5.3794 -4.5338 -4.0254 -4.9265
Nonoperating Income/Loss
97.43%
0.000106
0.00412 0.011 0.00415 -0.00544
Income/Loss From Continuing Operations Before Tax
34.05%
-3.5447
-5.3753 -4.5228 -4.0212 -4.9319
Income/Loss From Continuing Operations After Tax
34.05%
-3.5447
-5.3753 -4.5228 -4.0212 -4.9319
Net Income/Loss
34.05%
-3.5447
-5.3753 -4.5228 -4.0212 -4.9319
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,881%
8.7127
0.4397 4.1771 3.8773 1.9065
Diluted Average Shares
1,881%
8.7127
0.4397 4.1771 3.8773 1.9065
Basic Earnings Per Share
56.84%
-0.41
-0.95 -1.08 -1.04 -2.59
Diluted Earnings Per Share
56.84%
-0.41
-0.95 -1.08 -1.04 -2.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):